- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有2家主力机构披露2026-06-30报告期持股数据，持仓量总计16.77万股，占流通A股0.01%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了49%的股票
技术面评分前10的股票
近期的平均成本为8.59元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为8.59元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.59","date":1786610407,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2026.08.14","stock":"-0.23","trade":"0.21","ind":"0.01"},{"date":"2026.08.13","stock":"2.38","trade":"2.00","ind":"-0.50"},{"date":"2026.08.12","stock":"-0.71","trade":"-0.04","ind":"0.32"},{"date":"2026.08.11","stock":"0.84","trade":"1.19","ind":"-0.82"},{"date":"2026.08.10","stock":"-0.48","trade":"1.35","ind":"0.67"},{"date":"2026.08.07","stock":"3.82","trade":"6.42","ind":"1.02"},{"date":"2026.08.06","stock":"-1.82","trade":"-0.94","ind":"0.57"},{"date":"2026.08.05","stock":"-1.31","trade":"1.26","ind":"1.47"},{"date":"2026.08.04","stock":"0.12","trade":"2.90","ind":"0.33"},{"date":"2026.08.03","stock":"-0.12","trade":"0.14","ind":"-0.59"},{"date":"2026.07.31","stock":"0.36","trade":"2.21","ind":"0.72"},{"date":"2026.07.30","stock":"-1.07","trade":"-2.19","ind":"-0.62"},{"date":"2026.07.29","stock":"2.18","trade":"0.94","ind":"0.40"},{"date":"2026.07.28","stock":"2.48","trade":"-1.95","ind":"-1.16"},{"date":"2026.07.27","stock":"3.34","trade":"3.13","ind":"1.15"},{"date":"2026.07.24","stock":"-4.06","trade":"-3.95","ind":"-1.61"},{"date":"2026.07.23","stock":"-0.98","trade":"-0.26","ind":"0.25"},{"date":"2026.07.22","stock":"0.37","trade":"-0.90","ind":"0.07"},{"date":"2026.07.21","stock":"-0.85","trade":"-0.66","ind":"1.79"},{"date":"2026.07.20","stock":"2.87","trade":"0.38","ind":"0.85"},{"date":"2026.07.17","stock":"-6.64","trade":"-7.01","ind":"-3.05"}]
通化东宝,上证指数,生物制品指数
压力支撑
该股压力位为8.51元，支撑位为8.29元。
[{"text":"\u538b\u529b\u4f4d","value":"8.51","date":1786636800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.29","date":1786636800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.8资金面打败了18%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：08月14日 20:31
| 机构今日流向(万元) | -958.98 | 机构5日流向(万元) | -1855.91 |
| 机构10日流向(万元) | -534.94 | 机构20日流向(万元) | -3521.03 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少101351.79万股，其中基金净增仓1家，主力净减仓327家，暂未发现中长期投资价值。
截止2026-06-30，共2家主力机构（基金2家），持仓量总计16.77万股，占流通A股0.01%
其中，基金持仓与2025-12-31相比：
增仓：1家 ，增持 1.73万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有11.61万股
从主力名单中消失：328家 ，原持有101365.13万股
其中，基金持仓与2025-12-31相比：
增仓：1家 ，增持 1.73万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有11.61万股
从主力名单中消失：328家 ，原持有101365.13万股
消息面诊股
诊断结果：5.6消息面打败了53%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 行业周报|生物制品指数涨4.79%, 跑赢上证指数
2026-08-14 - 通化东宝：8月13日获融资买入3565.16万元
2026-08-14 - 通化东宝：8月12日获融资买入1690.74万元
2026-08-13 - 通化东宝：控股股东3200万股解押后再质押
2026-08-13 - 通化东宝：公司胰岛素西林瓶生产线项目目前处于建设推
2026-08-12 - 通化东宝甘精胰岛素正式递交美国BLA 国产胰岛素出
2026-08-12 - 通化东宝：8月11日获融资买入2801.47万元
2026-08-12 - 通化东宝：甘精胰岛素BLA已正式向美国 FDA 递
2026-08-11 - 通化东宝：1.62亿元认购特宝生物可转债获配售将上
2026-08-11 - 通化东宝：8月10日获融资买入2215.71万元
2026-08-11
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-29 |
| 一般消息 | 高管变动 | 因任期届满不再担任公司任何职务 | 2026-06-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-16 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-02 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-05-26 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-13 |
| 利好 | 分红转增 | 10派3元(含税) | 2026-04-20 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-01-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-31 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-31 |
| 一般消息 | 高管变动 | 公司内部工作调整 | 2025-11-03 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 高管变动 | 调整第十一届董事会审计委员会人员构... | 2025-08-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：8.5行业面打败了99%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2026.08.14","price":"0.01","value":"0.21"},{"date":"2026.08.13","price":"-0.50","value":"2.00"},{"date":"2026.08.12","price":"0.32","value":"-0.04"},{"date":"2026.08.11","price":"-0.82","value":"1.19"},{"date":"2026.08.10","price":"0.67","value":"1.35"},{"date":"2026.08.07","price":"1.02","value":"6.42"},{"date":"2026.08.06","price":"0.57","value":"-0.94"},{"date":"2026.08.05","price":"1.47","value":"1.26"},{"date":"2026.08.04","price":"0.33","value":"2.90"},{"date":"2026.08.03","price":"-0.59","value":"0.14"},{"date":"2026.07.31","price":"0.72","value":"2.21"},{"date":"2026.07.30","price":"-0.62","value":"-2.19"},{"date":"2026.07.29","price":"0.40","value":"0.94"},{"date":"2026.07.28","price":"-1.16","value":"-1.95"},{"date":"2026.07.27","price":"1.15","value":"3.13"},{"date":"2026.07.24","price":"-1.61","value":"-3.95"},{"date":"2026.07.23","price":"0.25","value":"-0.26"},{"date":"2026.07.22","price":"0.07","value":"-0.90"},{"date":"2026.07.21","price":"1.79","value":"-0.66"},{"date":"2026.07.20","price":"0.85","value":"0.38"},{"date":"2026.07.17","price":"-3.05","value":"-7.01"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 近岸蛋白 | 89.33% | 48.93% | 5.8分 |
| 2 | 百普赛斯 | 86.58% | 39.32% | 6.1分 |
| 3 | 义翘神州 | 86.57% | 20.64% | 6.5分 |
| 4 | - | 49.75% | 12.81% | 分 |
| 5 | 诺唯赞 | 47.93% | 7.54% | 6.8分 |
| 6 | 百奥泰 | 23.97% | 17.95% | 5.8分 |
| 8 | 诺诚健华 | 20.36% | 9.77% | 6.3分 |
| 10 | 万泽股份 | 17.71% | 1.11% | 5.3分 |
| 12 | 甘李药业 | 16.66% | 7.59% | 6.3分 |
| 14 | 君实生物 | 13.65% | 1.66% | 5.7分 |
| 16 | 昊帆生物 | 13.55% | 3.85% | 6.3分 |
| 18 | 派林生物 | 12.02% | 2.83% | 5.5分 |
| 20 | 金迪克 | 10.11% | 2.30% | 5.6分 |
| 22 | 迈威生物 | 9.68% | 11.44% | 6.0分 |
| 24 | 安科生物 | 9.41% | 4.68% | 5.7分 |
| 26 | 神州细胞 | 8.54% | 4.18% | 5.9分 |
| 28 | 百克生物 | 8.34% | 2.31% | 5.8分 |
| 30 | 通化东宝 | 6.99% | 1.78% | 5.5分 |
| 32 | 智飞生物 | 6.44% | -3.12% | 4.9分 |
| 34 | 特宝生物 | 5.68% | 8.65% | 5.9分 |
| 36 | 双成药业 | 4.96% | 2.26% | 5.7分 |
| 38 | 康泰生物 | 4.53% | -1.25% | 4.9分 |
| 40 | 四环生物 | 3.08% | -3.84% | 5.0分 |
| 42 | 康弘药业 | 2.77% | -0.44% | 5.3分 |
| 44 | 赛伦生物 | 1.99% | 1.90% | 6.2分 |
| 46 | 华兰生物 | 0.68% | -1.19% | 4.8分 |
| 48 | 博雅生物 | -0.32% | 0.06% | 4.8分 |
| 50 | 卫光生物 | -1.72% | -0.77% | 5.3分 |
| 52 | 康辰药业 | -4.33% | -0.64% | 6.3分 |
| 54 | 禾元生物 | -22.67% | 2.24% | 6.3分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 12/71 ， 25/71。
[{"date":"2026-03-31","value":"1.77","vol":"-6.01"},{"date":"2025-12-31","value":"18.08","vol":"-12.99"},{"date":"2025-09-30","value":"17.80","vol":"-10.09"},{"date":"2025-06-30","value":"3.48","vol":"-0.66"},{"date":"2025-03-31","value":"1.70","vol":"-0.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.77 | 18.08 | 17.80 | 3.48 | 1.70 |
| 行业(%) | -6.01 | -12.99 | -10.09 | -0.66 | -0.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"71.62","vol":"61.43"},{"date":"2025-12-31","value":"70.33","vol":"66.53"},{"date":"2025-09-30","value":"71.89","vol":"67.71"},{"date":"2025-06-30","value":"71.45","vol":"66.67"},{"date":"2025-03-31","value":"69.32","vol":"38.38"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
71.62 | 70.33 | 71.89 | 71.45 | 69.32 |
| 行业(%) | 61.43 | 66.53 | 67.71 | 66.67 | 38.38 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 21/71 ， 18/71。
[{"date":"2026-03-31","value":"14.76","vol":"297.05"},{"date":"2025-12-31","value":"46.66","vol":"39.85"},{"date":"2025-09-30","value":"50.55","vol":"45.81"},{"date":"2025-06-30","value":"85.60","vol":"6902.14"},{"date":"2025-03-31","value":"10.17","vol":"6125.11"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
14.76 | 46.66 | 50.55 | 85.60 | 10.17 |
| 行业(%) | 297.05 | 39.85 | 45.81 | 6902.14 | 6125.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"16.16","vol":"74.22"},{"date":"2025-12-31","value":"3005.63","vol":"33.79"},{"date":"2025-09-30","value":"1911.35","vol":"45.67"},{"date":"2025-06-30","value":"194.48","vol":"5.21"},{"date":"2025-03-31","value":"-49.15","vol":"-8.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
16.16 | 3005.63 | 1911.35 | 194.48 | -49.15 |
| 行业(%) | 74.22 | 33.79 | 45.67 | 5.21 | -8.79 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，居行业前列，两项指标的行业排名分别为 8/71 ， 14/71。
[{"date":"2026-03-31","value":"0.09","vol":"0.06"},{"date":"2025-12-31","value":"0.39","vol":"0.29"},{"date":"2025-09-30","value":"0.28","vol":"0.21"},{"date":"2025-06-30","value":"0.18","vol":"0.13"},{"date":"2025-03-31","value":"0.09","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.09 | 0.39 | 0.28 | 0.18 | 0.09 |
| 行业(次) | 0.06 | 0.29 | 0.21 | 0.13 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.32","vol":"0.29"},{"date":"2025-12-31","value":"1.21","vol":"1.29"},{"date":"2025-09-30","value":"0.83","vol":"0.90"},{"date":"2025-06-30","value":"0.53","vol":"0.55"},{"date":"2025-03-31","value":"0.27","vol":"0.25"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.32 | 1.21 | 0.83 | 0.53 | 0.27 |
| 行业(次) | 0.29 | 1.29 | 0.90 | 0.55 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"35.15","vol":"-78.67"},{"date":"2025-12-31","value":"40.25","vol":"12.85"},{"date":"2025-09-30","value":"7.80","vol":"0.21"},{"date":"2025-06-30","value":"30.25","vol":"-1377.65"},{"date":"2025-03-31","value":"15.19","vol":"-2083.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 35.15 | 40.25 | 7.80 | 30.25 | 15.19 |
| 行业 | -78.67 | 12.85 | 0.21 | -1377.65 | -2083.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.72","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.97","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.72 | - | 0.97 | - |
| 行业 | 0.00 | 1.74 | 0.00 | 1.55 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 35/71 ， 32/71。
[{"date":"2026-03-31","value":"4.84","vol":"6.66"},{"date":"2025-12-31","value":"5.04","vol":"5.80"},{"date":"2025-09-30","value":"4.64","vol":"6.07"},{"date":"2025-06-30","value":"1.76","vol":"6.57"},{"date":"2025-03-31","value":"2.89","vol":"7.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.84 | 5.04 | 4.64 | 1.76 | 2.89 |
| 行业 | 6.66 | 5.80 | 6.07 | 6.57 | 7.73 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"3.61","vol":"5.14"},{"date":"2025-12-31","value":"3.65","vol":"4.43"},{"date":"2025-09-30","value":"3.38","vol":"4.89"},{"date":"2025-06-30","value":"1.17","vol":"5.24"},{"date":"2025-03-31","value":"1.72","vol":"6.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.61 | 3.65 | 3.38 | 1.17 | 1.72 |
| 行业 | 5.14 | 4.43 | 4.89 | 5.24 | 6.33 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 34/71 ， 37/71。
[{"date":"2026-03-31","value":"12.27","vol":"28.78"},{"date":"2025-12-31","value":"10.10","vol":"28.75"},{"date":"2025-09-30","value":"12.46","vol":"28.02"},{"date":"2025-06-30","value":"21.80","vol":"26.19"},{"date":"2025-03-31","value":"13.73","vol":"26.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
12.27 | 10.10 | 12.46 | 21.80 | 13.73 |
| 行业(%) | 28.78 | 28.75 | 28.02 | 26.19 | 26.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.14","vol":"2.54"},{"date":"2025-12-31","value":"0.11","vol":"1.42"},{"date":"2025-09-30","value":"0.14","vol":"0.58"},{"date":"2025-06-30","value":"0.28","vol":"1.11"},{"date":"2025-03-31","value":"0.16","vol":"0.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.14 | 0.11 | 0.14 | 0.28 | 0.16 |
| 行业(%) | 2.54 | 1.42 | 0.58 | 1.11 | 0.80 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"15.82","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.19","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"6.41","blueLineValue":"0.33","type":"YC"}]